Institutional investors purchased a net $413.9 thousand shares of RXII during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 17.51% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 397.4 Thousand shares of Rxi Pharmaceuticals Corp
HUDSON BAY CAPITAL MANAGEMENT LP Bought 214.4 Thousand shares of Rxi Pharmaceuticals Corp